Full Text View
Tabular View
No Study Results Posted
Related Studies
Miltefosine to Treat Mucocutaneous Leishmaniasis
This study is currently recruiting participants.
Verified January 2011 by Paladin Labs (USA) Inc.
Study NCT01050907   Information provided by Paladin Labs (USA) Inc.

First Received on January 12, 2010.   Last Updated on January 18, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Leishmaniasis, Mucocutaneous
Cutaneous Leishmaniasis
Additional conditions recognized in this trial
Leishmaniasis
Leishmaniasis, Cutaneous
More general conditions related to this trial
Euglenozoa Infections
Parasitic Diseases
Protozoan Infections
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
miltefosine
More general drug interventions related to this trial
Anti-Infective Agents
Antifungal Agents
Antineoplastic Agents
Antiparasitic Agents
Antiprotozoal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Paladin Labs (USA) Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services